Clinical Trial Update: Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Caelyx (liposomal doxorubicin), cyclophosphamide, and Herceptin in metastatic breast cancer; results posted after compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Caelyx (liposomal doxorubicin)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Spanish Breast Cancer Research Group | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-07-15